Andrew K. Falconar

Identification of immunogenic and cross-reactive chikungunya virus epitopes for CD4+ T cells in chronic chikungunya disease

Evaluation of Zika rapid tests as aids for clinical diagnosis and epidemic preparedness

Enhanced Zika virus‐like particle development using <i>Baculovirus</i> spp. constructs

Isolation and characterisation of Leishmania donovani protein antigens from urine of visceral leishmaniasis patients

ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas

Spatiotemporal Heterogeneity in the Distribution of Chikungunya and Zika Virus Case Incidences during their 2014 to 2016 Epidemics in Barranquilla, Colombia

Recombination of B- and T-cell epitope-rich loci from Aedes- and Culex-borne flaviviruses shapes Zika virus epidemiology

Refining wet lab experiments with in silico searches: A rational quest for diagnostic peptides in visceral leishmaniasis

Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus–Specific CD8+ T Cells

Re-visiting the evolution, dispersal and epidemiology of Zika virus in Asia

Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis

Detection of Immunoglobulin G1 Against rK39 Improves Monitoring of Treatment Outcomes in Visceral Leishmaniasis

Erratum for Pettersson et al., “How Did Zika Virus Emerge in the Pacific Islands and Latin America?”

ZikaPLAN: Zika Preparedness Latin American Network

How Did Zika Virus Emerge in the Pacific Islands and Latin America?

IgG1 as a Potential Biomarker of Post-chemotherapeutic Relapse in Visceral Leishmaniasis, and Adaptation to a Rapid Diagnostic Test

Development of Peptide-Based Lineage-Specific Serology for Chronic Chagas Disease: Geographical and Clinical Distribution of Epitope Recognition

Significantly Lower Anti-Leishmania IgG Responses in Sudanese versus Indian Visceral Leishmaniasis